管理双转移性癌症的老年患者 - - 应对诊断和治疗方面的挑战
Zane Gray1, Nicholas Levonyak1,2, Liwei Jia3
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-8852, United States.
这项研究在患有并发症的患者中呈现了同时转移的前列腺癌和结直肠腺癌的病例. 一种化学激素疗法导致肝脏和肺部转移的持续完全缓解.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 临床医学 临床医学
背景情况:
- 前列腺和结肠直肠腺癌是美国非常普遍的原发性癌症.
- 改善的癌症存活率增加了二次原发性恶性瘤的发生率.
- 同时的诊断存在复杂的治疗挑战,因为不同的组织学和分子形状.
研究的目的:
- 报告一个独特的同时转移的前列腺癌和结直肠腺癌的病例.
- 为突出同时出现的先进恶性瘤的成功管理.
- 为了证明化学激素治疗方案在复杂患者中的有效性.
主要方法:
- 一个患有重大并发病症的患者的病例报告.
- 诊断同时转移的前列腺癌和结直肠腺癌.
- 用一种针对两种癌症的化学激素治疗方案进行治疗.
主要成果:
- 患者实现了肝脏和肺转移的持续完全缓解.
- 化学激素治疗方案在治疗双重原发性腺癌方面被证明是有效的.
- 尽管患者患有并发症,但观察到成功的治疗结果.
结论:
- 同时转移的前列腺和结直肠腺癌可以得到有效的管理.
- 化学激素治疗为复杂病例提供了可行的治疗选择.
- 这一案例强调了针对多种原发性癌症量身定制的治疗策略的重要性.
更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
相关概念视频
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Survival Analysis
